Our latest review of approved & investigational drugs including in combination with SGLT2 inhibitors now in Nature Cardiovascular Research:Current and future strategies for targeting the endothelin pathway in cardiovascular disease https://t.co/0jUDBO7fVK https://t.co/yfDw0y7HFo
Congratulations to our PI, Professor Anthony Davenport who has been awarded Honorary Fellowship by the British Pharmacological Society. https://t.co/cDNE7cJxhL
For excellence & leadership in science, healthcare & public service, @BritPharmSoc has awarded Honorary Fellowships to Prof. Peter Barnes, Catz Honorary Fellow since 2011, & Prof. Anthony Davenport, Catz Fellow since 1995: https://t.co/xiYLzDezoC @ImperialNHLI@DavenportLab
Congratulations to our PI, Prof Anthony Davenport who has been ranked one of the 2020 highest cited researchers (top 1% by citations for field and year in Web of Science) for two consecutive years...@Catz_Cambridge@Cambridge_Uni https://t.co/7qkzjTMuUX
A survey has revealed that 40% of early career researchers funded by charities like @TheBHF have considered leaving research over funding concerns.
@hmtreasury & @RishiSunak need to support #ResearchAtRisk.
I don’t want to hang up my lab coat for good.
https://t.co/qyWXwvPSRX
Our latest paper could help explain why age is major risk factor for dying from COVID-19, with people over 70 years at greatest risk, and why the disease can cause heart complications in severe cases. https://t.co/VqpNE1GO3k @Cambridge_Uni@Catz_Cambridge
Dagger to the heart: Genes encoding ACE2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes. @Cambridge_Uni@Catz_Cambridge https://t.co/rydL9jKTxJ
Check out our latest paper in Nature drug discovery on advances in the GPCR-targeted peptide therapeutics...@Catz_Cambridge@Cambridge_Uni
https://t.co/WdKByFcJoR
Our latest paper where we showed for the first time the metabolism of apelin in human and identified novel metabolites has been published. Thanks to everyone who contributed to it. @Cambridge_Uni@Catz_Cambridge
https://t.co/eGkgKJmpur
Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G Protein Biased Ligands at the Apelin Receptor.
https://t.co/QvzyVeANrV
Peptides
#GPCR#signaling#pharmacology
A fantastic two days at @BSCResearch Autumn Meeting 2019! Very interesting and inspiring talks! Our PhD students Tom and Robyn presented their work at the poster session. Congratulations to Robyn for winning a prize for her poster! @Cambridge_Uni@Catz_Cambridge@TheBHF
Congratulations to our group leader Dr Anthony Davenport on his graduation as Doctor of Science today!! Very well deserved, we're all very proud 🥳🥳🥳 @Cambridge_Uni@Catz_Cambridge
Well done to our PhD student, Robyn, who completed the BHF London to Brighton 54-mile bike ride yesterday! She was part of a group of BHF-funded Cambridge PhD students, who have collectively raised over £1,000! @Cambridgecardio@Cambridge_Uni@Catz_Cambridge
Two of our PhD students, Tom and Robyn, and rotation student, Elisabeth, presenting their work at the poster session at #BASBSCRSpring2019 meeting
@BSCResearch@britathsoc@Cambridgecardio - some great talks over the last two days!
Check out our latest paper on a novel G protein biased apelin agonist which has beneficial effects in pulmonary hypertension https://t.co/yk2L9iFVie. @Cambridge_Uni@Catz_Cambridge